Logo
x

Search

Subscribe Now

Fast Track Designation

Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia

Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia

  • January 22, 2025
Phanes Therapeutics’ PT217 Secures the US FDA’s Fast Track Designation for Neuroendocrine Prostate Cancer (NEPC)

Phanes Therapeutics’ PT217 Secures the US FDA’s Fast Track Designation for Neuroendocrine Prostate Cancer (NEPC)

  • December 5, 2024
Rigel’s R289 Secures the US FDA’s Fast Track Designation for Treating Lower-Risk Myelodysplastic Syndrome

Rigel’s R289 Secures the US FDA’s Fast Track Designation for Treating Lower-Risk Myelodysplastic Syndrome

  • December 3, 2024
Lin BioScience’s LBS-007 Secures the US FDA’s Fast Track Designation to Treat Acute Myeloid Leukemia

Lin BioScience’s LBS-007 Secures the US FDA’s Fast Track Designation to Treat Acute Myeloid Leukemia

  • November 28, 2024
New Drug Designations - October 2024

New Drug Designations - October 2024

  • November 26, 2024
New Drug Designations - September 2024

New Drug Designations - September 2024

  • October 29, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.